Stockscreener 앱 받기
2.52
1.20%
0.03
시간 외 거래:
2.52
전일 마감가:
$2.49
열려 있는:
$2.49
하루 거래량:
169.65K
Relative Volume:
1.25
시가총액:
$73.33M
수익:
-
순이익/손실:
$-75.52M
주가수익비율:
-0.875
EPS:
-2.88
순현금흐름:
$-56.92M
1주 성능:
+0.40%
1개월 성능:
-0.40%
6개월 성능:
+21.15%
1년 성능:
-89.94%
1일 변동 폭
$2.49
$2.57
1주일 범위
$2.45
$2.575
52주 변동 폭
$1.25
$28.70
Aerovate Therapeutics Inc Stock (AVTE) Company Profile
명칭
Aerovate Therapeutics Inc
전화
617-443-2400
주소
930 WINTER STREET, WALTHAM
AVTE을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AVTE
Aerovate Therapeutics Inc
|
2.52 | 73.33M | 0 | -75.52M | -56.92M | -2.88 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.56 | 121.88B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.78 | 62.69B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
550.00 | 32.85B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
232.95 | 28.75B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
220.54 | 25.69B | 3.81B | -644.79M | -669.77M | -6.24 |
Aerovate Therapeutics Inc Stock (AVTE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-06-18 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2024-06-18 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2024-06-18 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2024-06-17 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2024-06-17 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2024-06-17 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2024-03-25 | 재개 | Jefferies | Buy |
| 2023-12-08 | 개시 | Wells Fargo | Equal Weight |
| 2023-03-01 | 개시 | Guggenheim | Buy |
| 2022-12-06 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2022-09-19 | 재개 | Wedbush | Outperform |
| 2022-08-16 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2022-02-11 | 개시 | BTIG Research | Buy |
| 2021-07-26 | 개시 | Cowen | Outperform |
| 2021-07-26 | 개시 | Evercore ISI | Outperform |
| 2021-07-26 | 개시 | Jefferies | Buy |
| 2021-07-26 | 개시 | Wedbush | Outperform |
모두보기
Aerovate Therapeutics Inc 주식(AVTE)의 최신 뉴스
Aerovate Therapeutics Announces Range Of Expected Cash Dividend - MarketScreener
Aerovate signals cash dividend ahead of Jade merger - Investing.com
Aerovate Therapeutics Announces Range of Expected Cash Dividend in Connection with the Proposed Merger with Jade Biosciences - PR Newswire
36,897 Shares in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Acquired by Corient Private Wealth LLC - Defense World
$HAREHOLDER ALERT: The M&A Class Action Firm Urges Stockholders of AMPY, HEES, AVTE, TGI to Act Now - GlobeNewswire Inc.
Aerovate Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Aerovate Therapeutics Inc. (AVTE) reports earnings - Quartz
Aerovate Therapeutics Inc expected to post a loss of 25 cents a shareEarnings Preview - TradingView
AEROVATE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Aerovate Therapeutics, Inc.AVTE - Business Wire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AMPS, PTMN, AVTE on Behalf of Shareholders - The Malaysian Reserve
Aerovate Therapeutics (AVTE) Expected to Announce Quarterly Earnings on Monday - Defense World
FY2029 Earnings Estimate for AVTE Issued By Wedbush - MarketBeat
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AVTE, BMTX, PFIE, ALTR on Behalf of Shareholders - ACCESS Newswire
FY2029 Earnings Forecast for AVTE Issued By Wedbush - Defense World
In Another Blow to Delaware's Hegemony Another Company Proposes Reincorporation in Nevada - The National Law Review
$HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The MergerCCNE, LGTY, AVTE, PLYA - Longview News-Journal
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BRDG, AVTE, BLUE on Behalf of Shareholders - Stockhouse Publishing
Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Sees Significant Increase in Short Interest - MarketBeat
Ready to Jump After Recent Trade: Aerovate Therapeutics Inc (AVTE) - SETE News
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates IVAC, AVTE, QTRX on Behalf of Shareholders - EIN News
Deltec Asset Management LLC Invests $514,000 in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - MarketBeat
Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Sees Significant Growth in Short Interest - MarketBeat
Barclays PLC Raises Holdings in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - Defense World
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates MHLD, IPG, AVTE on Behalf of Shareholders - GlobeNewswire
AVTE Stock Price and Chart — NASDAQ:AVTE - TradingView
Aerovate Therapeutics Target of Unusually Large Options Trading (NASDAQ:AVTE) - MarketBeat
Jane Street Group LLC Trims Holdings in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - MarketBeat
Jane Street Group LLC Trims Position in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - Defense World
Short Interest in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Increases By 35.5% - MarketBeat
Unusually active option classes on open January 16th - TipRanks
Geode Capital Management LLC Sells 25,287 Shares of Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - Defense World
Barclays PLC Has $39,000 Holdings in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - Defense World
Analyzing Kronos Bio (NASDAQ:KRON) and Aerovate Therapeutics (NASDAQ:AVTE) - Defense World
State Street Corp Raises Stock Holdings in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - Defense World
AVTE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Aerovate Therapeutics, Inc. Is Fair to Shareholders - Business Wire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AVTE, STAF, ALVR on Behalf of Shareholders - The Eastern Progress Online
Fmr LLC Boosts Stock Position in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - Defense World
Charles Schwab Investment Management Inc. Reduces Position in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - Defense World
STOCKHOLDER ALERT: The M&A Class Action Firm Continues To Investigate MergerAVTE, BCOV, ALVR, AE - cnhinews.com
Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Short Interest Update - Defense World
Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Short Interest Down 5.3% in November - MarketBeat
INVESTOR ALERT: The M&A Class Action Firm Investigates the Merger of Aerovate Therapeutics, Inc.AVTE - The Eastern Progress Online
Verition Fund Management LLC Sells 149,137 Shares of Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - Defense World
Pulmonary Arterial Hypertension Market to Show Remarkable Growth Trends from 2024 to 2034, DelveInsight Reports | Novartis, Insmed Inc, Chugai Pharma, Merck Sharp & Dohme, Janssen Pharma, Aerovate - The Globe and Mail
Aerovate Therapeutics Inc (AVTE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.48%
자본화:
|
볼륨(24시간):